Please use this identifier to cite or link to this item:
https://repository.unad.edu.co/handle/10596/65326Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.advisor | Pacheco, Miguel | |
| dc.coverage.spatial | udr_-_Cali | |
| dc.creator | Ana María Rodríguez Molina | |
| dc.creator | Jenny Marcela Lavado Ahumada | |
| dc.creator | Paula Juliet Galeano González | |
| dc.creator | Luifer Castellanos López | |
| dc.creator | Valeria Apraez Apraez | |
| dc.date.accessioned | 2024-12-17T20:49:55Z | - |
| dc.date.available | 2024-12-17T20:49:55Z | - |
| dc.date.created | 2024-12-13 | |
| dc.identifier.uri | https://repository.unad.edu.co/handle/10596/65326 | - |
| dc.description.abstract | El presente documento aborda las interacciones medicamentosas (IM) como un problema de salud pública, especialmente en pacientes polimedicados. Se identifican factores de riesgo, como la polifarmacia y las comorbilidades, que aumentan la probabilidad de IM. También se revisan estrategias preventivas, como el uso de herramientas tecnológicas, educación continua para profesionales de la salud y protocolos estandarizados. Finalmente, se propone la capacitación de farmacéuticos para mejorar la gestión de las IM y optimizar la farmacoterapia. | |
| dc.format | ||
| dc.title | Prevención y manejo de interacciones farmacológicas en pacientes polimedicados | |
| dc.type | Diplomado de profundización para grado | |
| dc.subject.keywords | Interacciones medicamentosas | |
| dc.subject.keywords | polifarmacia | |
| dc.subject.keywords | estrategias preventivas | |
| dc.subject.keywords | farmacéuticos | |
| dc.subject.keywords | capacitación | |
| dc.description.abstractenglish | This document examines drug-drug interactions (DDIs) as a public health issue, especially among polypharmacy patients. It identifies risk factors, such as polypharmacy and comorbidities, that increase the likelihood of DDIs. Preventive strategies, such as the use of technological tools, continuous education for healthcare professionals, and standardized protocols, are reviewed. Finally, pharmacist training is proposed to enhance DDI management and optimize pharmacotherapy. | |
| dc.subject.category | Farmacovigilancia | |
| Appears in Collections: | Diplomado de Farmacovigilancia | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| jmlavadoa.pdf | 356.09 kB | Adobe PDF |  View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.